Medicare Enrolled

Dr. Irina Raklyar, MD

Rheumatology · Franklin Lakes, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
784 FRANKLIN AVE, Franklin Lakes, NJ 07417
8447770910
In practice since 2007 (19 years)
NPI: 1356486831 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Raklyar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Raklyar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Raklyar

Dr. Irina Raklyar is a rheumatology specialist in Franklin Lakes, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Raklyar performed 2,667 Medicare services across 398 unique beneficiaries.

Between the years covered by Open Payments, Dr. Raklyar received a total of $9,977 from 52 pharmaceutical and/or device companies across 664 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Raklyar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 2,667 Medicare services $9,977 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,667
Medicare services
Bottom 38% in NJ for rheumatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
398
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~140 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,920 $18 $90
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
247 $102 $500
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
127 $76 $400
Injection, methylprednisolone acetate, 40 mg 94 $6 $50
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
89 $96 $2,784
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
61 $149 $600
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
58 $13 $500
Methylprednisolone acetate injection, 20 mg
A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered.
33 $4 $25
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
26 $140 $550
New patient office visit, complex (60-74 min) 12 $192 $600
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,977
Total received (2018-2024)
Avg $1,425/year across 7 years
Top 20% in NJ for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
664
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,660 (96.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$317 (3.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,203
2023
$1,233
2022
$920
2021
$1,273
2020
$1,001
2019
$2,144
2018
$2,203

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$265
Amgen Inc.
$239
Novartis Pharmaceuticals Corporation
$165
UCB, Inc.
$139
AstraZeneca Pharmaceuticals LP
$98
SCILEX PHARMACEUTICALS INC.
$86
ANI Pharmaceuticals, Inc.
$34
E.R. Squibb & Sons, L.L.C.
$34
Aurinia Pharma U.S., Inc.
$33
Janssen Biotech, Inc.
$30
GENZYME CORPORATION
$18
Alvogen Inc
$18
GlaxoSmithKline, LLC.
$15
Alexion Pharmaceuticals, Inc.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Top 3 companies account for 55.7% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,521
Novartis Pharmaceuticals Corporation
$872
UCB, Inc.
$853
Janssen Biotech, Inc.
$721
PFIZER INC.
$672
ABBVIE INC.
$629
Lilly USA, LLC
$451
Genentech USA, Inc.
$330
E.R. Squibb & Sons, L.L.C.
$313
GlaxoSmithKline, LLC.
$303
GENZYME CORPORATION
$271
Radius Health, Inc.
$256
AbbVie Inc.
$253
DePuy Synthes Sales Inc.
$241
AstraZeneca Pharmaceuticals LP
$234
AbbVie, Inc.
$234
Genentech, Inc.
$228
Ferring Pharmaceuticals Inc.
$155
Horizon Therapeutics plc
$142
Horizon Pharma plc
$135
SCILEX PHARMACEUTICALS INC.
$86
Sobi, Inc
$82
Aurinia Pharma U.S., Inc.
$79
Mallinckrodt Enterprises LLC
$73
Alexion Pharmaceuticals, Inc.
$73
Flexion Therapeutics, Inc.
$71
Takeda Pharmaceuticals U.S.A., Inc.
$56
Antares Pharma, Inc.
$56
SOBI, INC
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$41
Pacira Therapeutics, Inc.
$40
MEDEXUS PHARMA, INC.
$38
MEDAC PHARMA, INC.
$37
Fidia Pharma USA Inc.
$34
Ultragenyx Pharmaceutical Inc.
$34
ANI Pharmaceuticals, Inc.
$34
FIDIA PHARMA USA INC.
$30
Zyla Life Sciences, Inc.
$30
Integra LifeSciences Corporation
$22
SI-BONE, Inc.
$20
Alvogen Inc
$18
Kyowa Kirin, Inc.
$17
Mission Pharmacal Company
$15
Novo Nordisk Inc
$15
Fresenius Kabi USA, LLC
$15
Organon LLC
$14
Mallinckrodt Hospital Products Inc.
$14
West-Ward Pharmaceuticals
$14
SANOFI-AVENTIS U.S. LLC
$14
Mallinckrodt LLC
$14
Kowa Pharmaceuticals America, Inc.
$13
Zyla Life Sciences
$13
Top 3 companies account for 32.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Aquoral · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUEXIS · EUFLEXXA · EVENITY · Enbrel · FORTEO · GLOPERBA · HUMIRA · HYMOVIS · Humira · Hymovis · ILARIS · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · NUCALA · OFEV · ORENCIA · ORTHOVISC · Otrexup · Ozempic · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · REYVOW · RINVOQ · Rasuvo · Rinvoq · Rituxan · SALTO TALARIS TOTAL ANKLE PROSTHESIS · SEGLENTIS · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · STRENSIQ · Sodium Chloride · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · Uloric · XELJANZ · ZTLido · Zilretta · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Franklin Lakes?
Compare rheumatologists in the Franklin Lakes area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
284
Per 100K population
29.7
County median income
$123,715
Nearest hospital
RAMAPO RIDGE BEHAVIORAL HEALTH HOSPITAL
2.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Raklyar is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 20% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Raklyar experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Raklyar performed 1,920 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Raklyar receive payments from pharmaceutical companies?
Yes. Dr. Raklyar received a total of $9,977 from 52 companies across 664 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Raklyar's costs compare to other rheumatologists in Franklin Lakes?
Dr. Raklyar's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Raklyar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →